Literature DB >> 26641550

A2E Suppresses Regulatory Function of RPE Cells in Th1 Cell Differentiation Via Production of IL-1β and Inhibition of PGE2.

Qian Shi1, Qiu Wang2, Jing Li3, Xiaohui Zhou3, Huimin Fan3, Fenghua Wang2, Haiyun Liu2, Xiangjun Sun4, Xiaodong Sun5.   

Abstract

PURPOSE: Inflammatory status of RPE cells induced by A2E is essential in the development of AMD. Recent research indicated T-cell immunity was involved in the pathological progression of AMD. This study was designed to investigate how A2E suppresses immunoregulatory function of RPE cells in T-cell immunity in vitro.
METHODS: Mouse RPE cells or human ARPE19 cells were stimulated with A2E, and co-cultured with naïve T cells under Th1, Th2, Th17, and regulatory T cell (Treg) polarization conditions. The intracellular cytokines or transcript factors of the induced T-cells subset were detected with flow cytometer and qRT-PCR. The ROS levels were detected, and the factors and possible pathways involved in the A2E-laden RPE cells were analyzed through neutralization antibody of IL-1β and inhibitors of related pathways.
RESULTS: The A2E reduced regulatory function of RPE cells in Treg differentiation. The A2E-laden RPE cells promoted polarization of Th1 cells in vitro, but not Th2 or Th17 differentiation. The A2E induced RPE cells to release inflammatory cytokines and ROS, but PGE2 production was inhibited. Through neutralization of IL-1β or inhibition of COX2-PGE2 pathways, A2E-laden RPE cells expressed reduced effect in inducing Th1 cells.
CONCLUSIONS: The A2E inhibited regulatory function of RPE cells in suppressing Th1 cell immunity in vitro through production of IL-1β and inhibition of PGE2. Our data indicate that A2E could suppress immunoregulatory function of RPE cells and adaptive immunity might play a role in the immune pathogenesis of AMD.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26641550     DOI: 10.1167/iovs.15-17677

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  8 in total

Review 1.  Therapeutic Potential of Microvesicles in Cell Therapy and Regenerative Medicine of Ocular Diseases With an Especial Focus on Mesenchymal Stem Cells-Derived Microvesicles.

Authors:  Lina Moallemi Rad; Alexey V Yumashev; Bashdar Mahmud Hussen; Hazha Hadayat Jamad; Soudeh Ghafouri-Fard; Mohammad Taheri; Samaneh Rostami; Vahid Niazi; Mohammadreza Hajiesmaeili
Journal:  Front Genet       Date:  2022-03-29       Impact factor: 4.599

Review 2.  Recent advances of exosomes in immune-mediated eye diseases.

Authors:  Na Li; Lu Zhao; Yankai Wei; Vicki L Ea; Hong Nian; Ruihua Wei
Journal:  Stem Cell Res Ther       Date:  2019-08-30       Impact factor: 6.832

Review 3.  The Role of Inflammation in Age-Related Macular Degeneration.

Authors:  Wei Tan; Jingling Zou; Shigeo Yoshida; Bing Jiang; Yedi Zhou
Journal:  Int J Biol Sci       Date:  2020-09-23       Impact factor: 6.580

Review 4.  Mesenchymal Stem Cell-Derived Secretome: A Potential Therapeutic Option for Autoimmune and Immune-Mediated Inflammatory Diseases.

Authors:  Györgyi Műzes; Ferenc Sipos
Journal:  Cells       Date:  2022-07-26       Impact factor: 7.666

5.  Photosensitization of A2E triggers telomere dysfunction and accelerates retinal pigment epithelium senescence.

Authors:  Jing Wang; Yiji Feng; Peng Han; Fenghua Wang; Xueting Luo; Jian Liang; Xiangjun Sun; Jing Ye; Yiming Lu; Xiaodong Sun
Journal:  Cell Death Dis       Date:  2018-02-07       Impact factor: 8.469

Review 6.  IL-1 Family Members Mediate Cell Death, Inflammation and Angiogenesis in Retinal Degenerative Diseases.

Authors:  Yvette Wooff; Si Ming Man; Riemke Aggio-Bruce; Riccardo Natoli; Nilisha Fernando
Journal:  Front Immunol       Date:  2019-07-16       Impact factor: 7.561

Review 7.  Potential Role of Myeloid-Derived Suppressor Cells (MDSCs) in Age-Related Macular Degeneration (AMD).

Authors:  Anu Kauppinen; Kai Kaarniranta; Antero Salminen
Journal:  Front Immunol       Date:  2020-03-20       Impact factor: 7.561

8.  ROS production and mitochondrial dysfunction driven by PU.1-regulated NOX4-p22phox activation in Aβ-induced retinal pigment epithelial cell injury.

Authors:  Junran Sun; Jieqiong Chen; Tong Li; Peirong Huang; Jie Li; Mengxi Shen; Min Gao; Yang Sun; Jian Liang; Xiaomeng Li; Yimin Wang; Yushu Xiao; Xiang Shi; Yifan Hu; Jingyang Feng; Huixun Jia; Te Liu; Xiaodong Sun
Journal:  Theranostics       Date:  2020-09-19       Impact factor: 11.556

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.